Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
200710.8k citationsHiroko Ohgaki, Otmar D. Wiestler et al.Digital Access to Scholarship at Harvard (DASH) (Harvard University)profile →
Erratum to: The 2007 WHO classification of tumours of the central nervous system
20073.1k citationsDavid N. Louis, Hiroko Ohgaki et al.profile →
Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination
20002.5k citationsJoseph E. Parisi, Bernd W. Scheithauer et al.profile →
The WHO Classification of Tumors of the Nervous System
20021.5k citationsPaul Kleihues, David N. Louis et al.profile →
Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases
19861.1k citationsBernd W. Scheithauer, Duane M. Ilstrup et al.profile →
Inflammatory Cortical Demyelination in Early Multiple Sclerosis
2011827 citationsJoseph E. Parisi, Bernd W. Scheithauer et al.profile →
Grading of astrocytomas: A simple and reproducible method
1988700 citationsBernd W. Scheithauer et al.profile →
Donor-Derived Brain Tumor Following Neural Stem Cell Transplantation in an Ataxia Telangiectasia Patient
2009684 citationsBernd W. Scheithauer et al.profile →
Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms
1987643 citationsBernd W. Scheithauer et al.profile →
Alterations of Chromosome Arms 1p and 19q as Predictors of Survival in Oligodendrogliomas, Astrocytomas, and Mixed Oligoastrocytomas
2000643 citationsJustin S. Smith, Arie Perry et al.Journal of Clinical Oncologyprofile →
Phase II Trial of Temsirolimus (CCI-779) in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study
2005550 citationsEvanthia Galanis, Jan C. Buckner et al.Journal of Clinical Oncologyprofile →
p27kip1: A Multifunctional Cyclin-Dependent Kinase Inhibitor with Prognostic Significance in Human Cancers
1999517 citationsRicardo V. Lloyd, Bernd W. Scheithauer et al.profile →
Phase III Trial of Chemotherapy Plus Radiotherapy Compared With Radiotherapy Alone for Pure and Mixed Anaplastic Oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402
2006508 citationsGregory Cairncross, Brian Berkey et al.Journal of Clinical Oncologyprofile →
Dysembryoplastic Neuroepithelial Tumor: A Surgically Curable Tumor of Young Patients with Intractable Partial Seizures
1988493 citationsBernd W. Scheithauer, Edward R. Laws et al.Neurosurgeryprofile →
Author Peers
Peers are selected by citation overlap in the author's most active subfields.
citations ·
hero ref
Countries citing papers authored by Bernd W. Scheithauer
Since
Specialization
Citations
This map shows the geographic impact of Bernd W. Scheithauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernd W. Scheithauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernd W. Scheithauer more than expected).
Fields of papers citing papers by Bernd W. Scheithauer
This network shows the impact of papers produced by Bernd W. Scheithauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernd W. Scheithauer. The network helps show where Bernd W. Scheithauer may publish in the future.
Co-authorship network of co-authors of Bernd W. Scheithauer
This figure shows the co-authorship network connecting the top 25 collaborators of Bernd W. Scheithauer.
A scholar is included among the top collaborators of Bernd W. Scheithauer based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Bernd W. Scheithauer. Bernd W. Scheithauer is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Jentoft, Mark E., Caterina Giannini, Ling Cen, et al.. (2010). Phenotypic variations in NF1-associated low grade astrocytomas: possible role for increased mTOR activation in a subset.. PubMed Central.22 indexed citations
Cairncross, Gregory, Brian Berkey, Edward Shaw, et al.. (2006). Phase III Trial of Chemotherapy Plus Radiotherapy Compared With Radiotherapy Alone for Pure and Mixed Anaplastic Oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. Journal of Clinical Oncology. 24(18). 2707–2714.508 indexed citations breakdown →
Brat, Daniel J., Bernd W. Scheithauer, Susan M. Staugaitis, et al.. (2000). Pituicytoma. The American Journal of Surgical Pathology. 24(3). 362–368.154 indexed citations
Komori, Takashi, Bernd W. Scheithauer, Douglas C. Anthony, et al.. (1998). Papillary Glioneuronal Tumor. The American Journal of Surgical Pathology. 22(10). 1171–1183.135 indexed citations
Mitchell, Andrew, Bernd W. Scheithauer, Michael J. Ebersold, & Glenn S. Forbes. (1991). Intracranial Fibromatosis. Neurosurgery. 29(1). 123–126.13 indexed citations
20.
Jack, Clifford R., David F. Reese, & Bernd W. Scheithauer. (1985). Radiographic Findings in 32 Cases of Primary CNS Lymphoma. American Journal of Neuroradiology. 21(10). 899–904.11 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.